Extension of the interval between vaccine doses for the BNT162b2 mRNA vaccine was
introduced in the United Kingdom to accelerate population coverage with a single dose. At this …

The complement system is a key component of innate immunity which readily responds to
invading microorganisms. Activation of the complement system typically occurs via three main …

Ebola viruses are enveloped, single-stranded RNA viruses belonging to the Filoviridae family
and can cause Ebola virus disease (EVD), a serious haemorrhagic illness with up to 90% …

Background Previous infection with SARS-CoV-2 affects the immune response to the first
dose of the SARS-CoV-2 vaccine. We aimed to compare SARS-CoV-2-specific T-cell and …

There is a vital need for authentic COVID-19 animal models to enable the pre-clinical evaluation
of candidate vaccines and therapeutics. Here we report a dose titration study of SARS-…

Mucosal immune responses are in the first line of defense against most infections and
protective mucosal immunity can be achieved by mucosal vaccination. However, mucosal …

The available virus-like particle (VLP)-based prophylactic vaccines against specific human
papillomavirus (HPV) types afford close to 100% protection against the type-associated …

A novel coronavirus, SARS-CoV-2, has been identified as the causative agent of the current
COVID-19 pandemic. Animal models, and in particular non-human primates, are essential to …

The extent to which immune responses to natural infection with severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) and immunization with vaccines protect against variants …

Two doses of BNT162b2 mRNA vaccine induces a strong systemic SARS-CoV-2 specific
humoral response. However, SARS-CoV-2 airborne transmission makes mucosal immune …